Efficient gene transfer to airway epithelium using recombinant Sendai virus
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Clinical studies of gene therapy for cystic fibrosis (CF) suggest that the key problem is the efficiency of gene transfer to the airway epithelium. The availability of relevant vector receptors, the transient contact time between vector and epithelium, and the barrier function of airway mucus contribute significantly to this problem. We have recently developed recombinant Sendai virus (SeV) as a new gene transfer agent. Here we show that SeV produces efficient transfection throughout the respiratory tract of both mice and ferrets in vivo, as well as in freshly obtained human nasal epithelial cells in vitro. Gene transfer efficiency was several log orders greater than with cationic liposomes or adenovirus. Even very brief contact time was sufficient to produce this effect, and levels of expression were not significantly reduced by airway mucus. Our investigations suggest that SeV may provide a useful new vector for airway gene transfer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although both methods have low reprogramming efficiency, Sendai virus-mediated reprogramming has been used for several clinical applications, notably, in cystic fibrosis, the AIDS vaccine, and other iPSC replacement therapies [29,30,31,32,33].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [29]
Citations
Cites
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089 · cited 1×
“Recombinant SeVs were constructed and propagated as previously describe”
MethodLiposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 711
Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 681
Submucosal glands are the predominant site of CFTR expression in the human bronchus
Engelhardt, J. F., Yankaskas, J. R., Ernst, S. A., Yang, Y., Marino, C. R., Boucher, R. C., Cohn, J. A., & Wilson, J. M. (1992) · Nature Genetics · doi:10.1038/ng1192-240 · Cited by 653 · cited 1×
“2E ), the predominant site of CFTR expression in the human bronchu”
BackgroundLee, E. R., Marshall, J., Siegel, C. S., Jiang, C., Yew, N. S., Nichols, M. R., Nietupski, J. B., Ziegler, R. J., Lane, M. B., Wang, K. X., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.14-1701 · Cited by 443 · cited 1×
“, or the plasmid pCMV-luc complexed to GL-67/DOPE/DMPE-PEG 5000 (80 μg DNA/mouse) were placed as a single 100 μl bolus into the nasal cavity of male BALB/c mice (six to eight weeks), and the solution was sniffed into the lung”
MethodEfficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., & Boucher, R. C. (1992) · Nature Genetics · doi:10.1038/ng0992-21 · Cited by 439 · cited 1×
“Laboratory studies suggest that correction of the CF chloride defect can be achieved by introducing ∼6–10% of corrected cells overexpressing CFTR into a CF monolaye”
BackgroundAlton, E., Stern, M., Farley, R., Jaffe, A., Chadwick, S., Phillips, J., Davies, J., Smith, S., Browning, J., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 435
Porteous, D., Dorin, Jr., McLachlan, G., Davidson-Smith, H., Davidson, H., Stevenson, B., Carothers, A., Wallace, W., Moralee, S., Hoenes, C., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300390 · Cited by 324
Specific gangliosides function as host cell receptors for Sendai virus.
Markwell, M. A., Svennerholm, L., & Paulson, J. C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5406 · Cited by 259 · cited 1×
“The receptor for SeV is sialic acid bound to gangliosides, present on most cell types, including the apical surface of the conducting airway”
BackgroundExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo
Ferrari, S., Moro, E., Pettenazzo, A., Behr, J., Zacchello, F., & Scarpa, M. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300503 · Cited by 256 · cited 1×
“Two days post infection, ferrets were killed and the lungs fixed by intratracheal perfusion of fixative solution, excised en bloc, processed, and stained with X-Gal as described by Ferrari and colleague”
MethodKato, A., Sakai, Y., Shioda, T., Kondo, T., Nakanishi, M., & Nagai, Y. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.d01-261.x · Cited by 231 · cited 1×
“The rodent lung is the natural host of the wild-type SeV strain that was used to construct the recombinant viru”
BackgroundThe paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis
Kato, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.578 · Cited by 209 · cited 1×
“Recombinant Sendai virus (SeV), a member of the paramyxovirida”
BackgroundMatsui, H., Johnson, L. G., Randell, S. H., & Boucher, R. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1117 · Cited by 197
Pack, R. J., Al-Ugaily, L., & Morris, G. (1981) · Europe PMC (PubMed Central) · Cited by 190
Moyer, S. A., Baker, S. C., & Lessard, J. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5405 · Cited by 181 · cited 1×
“Finally, SeV mediates gene transfer to a cytoplasmic locatio”
BackgroundHay, J. G., McElvaney, N. G., Herena, J., & Crystal, R. G. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.11-1487 · Cited by 136
Kitson, C., Angel, B., Judd, D., ROTHERY, S. M., Severs, N. J., Dewar, A. L., Huang, L., Wadsworth, S., Cheng, S. H., Geddes, D. M., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300840 · Cited by 134
Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time
Zabner, J., Zeiher, B. G., Friedman, E., & Welsh, M. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6994-7003.1996 · Cited by 124
Hasan, M. K., Nagai, Y., Yu, D., Sakai, Y., Kato, A., & Shioda, T. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-11-2813 · Cited by 98 · cited 1×
“Recombinant Sendai virus (SeV), a member of the paramyxovirida”
BackgroundDuan, D., Sehgal, A., Yao, J., & Engelhardt, J. F. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.6.2987 · Cited by 63 · cited 1×
“The lung morphology, mucin composition, and density of submucosal glands of these animals are similar to those in human”
BackgroundStern, M., Munkonge, F. M., Caplen, N. J., Sorgi, F., Huang, L., Geddes, D. M., & Alton, E. W. F. W. (1995) · PubMed · Cited by 49
Yonemitsu, Y., Kaneda, Y., Muraishi, A., Yoshizumi, T., Sugimachi, K., & Sueishi, K. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300463 · Cited by 31 · cited 1×
“Two days after gene transfer, nasal turbinates and lungs were harvested and assayed for luciferase activit”
MethodMassion, P. P., Funari, C. C. P., Ueki, I. F., Ikeda, S., McDonald, D. M., & Nadel, J. A. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/9.4.361 · Cited by 27
Agonistmstimulated free calcium in subcellular compartments
Kendall, J. M., Badminton, M. N., Sala‐Newby, G. B., Wilkinson, G. W. G., & Campbell, A. K. (1996) · Cell Calcium · doi:10.1016/s0143-4160(96)90082-2 · Cited by 25
Hemagglutinating Virus of Japan Liposome-Mediated Gene Delivery to Vascular Cells
Yonemitsu, Y., & Kaneda, Y. (2003) · Humana Press eBooks · doi:10.1385/1-59259-247-3:295 · Cited by 17
Cited by
FUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411
Self-citationNALT- versus PEYER'S-patch-mediated mucosal immunity
Kiyono, H., & Fukuyama, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1439 · Cited by 745
“www.nature.com/reviews/immunol R E V I E W S guides antigen to the mucosal epithelium, because the Sendai virus itself uses this fusion protein for the invasion of respiratory epithelial cells 74 .”
BackgroundZhang, L., Peeples, M. E., Boucher, R. C., Collins, P. L., & Pickles, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5654-5666.2002 · Cited by 581
“Sendai virus vectors have been shown to infect ciliated cells of the rodent airway (43), but the efficiency with which this rodent virus infects HAE cells remains to be determined.”
BackgroundKobinger, G. P., Weiner, D. J., Yu, Q.-C., & Wilson, J. M. (2001) · Nature Biotechnology · doi:10.1038/85664 · Cited by 307
Cu, Y., & Saltzman, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8001254 · Cited by 267
Metadata
- Authors
- Yonemitsu, Y., Kitson, C., Ferrari, S., Farley, R., Griesenbach, U., Judd, D., Steel, R., Scheid, P., Zhu, J., Jeffery, P. K., Kato, A., Hasan, M. K., Nagai, Y., Masaki, I., Fukumura, M., Hasegawa, M., Geddes, D. M., & Alton, E. W. F. W.
- Affiliations
- Imperial College London (GB)
- National Institute of Infectious Diseases (JP)
- Kyushu University (JP)
- ID Pharma (Japan) (JP)
- Corresponding author
- Alton, Eric W.F.W.
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2000-09
- Volume
- 18
- Issue
- 9
- Pages
- 970-973
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1553961669
- Cited by
- 244
- References
- 25
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 10 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 11 · 2012: 8
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- cystic fibrosis gene therapy, nasal epithelial cells, cationic liposomes, ferrets, mice
- MeSH terms
- Adenoviridae, Animals, Bronchi, Cell Line, Cells, Cultured, Cystic Fibrosis, Dogs, Dose-Response Relationship, Drug, Epithelium, Female, Ferrets, Genetic Vectors, Humans, Liposomes, Luciferases, Lung, Male, Mice, Inbred BALB C, Mucous Membrane, Nasal Mucosa, Receptors, Cell Surface, Sheep, Time Factors, Trachea, Transfection, Gene Transfer Techniques, Respirovirus, COS Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.